로딩 중…
지수 로딩 중…
Viking Therapeutics, Inc.
VKTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$30.38+0.30%
2026-06-18
Price Chart
Viking Therapeutics, Inc.+15.60%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $3.53B |
| Revenue | $0.00 |
| Net Income | $-472M |
| Total Assets | $608M |
| Net Assets | $502M |
| Value | |
| P/B | 7.03x |
| FCF Yield | -9.65% |
| Profitability | |
| ROE | -94.11% |
| ROA | -77.66% |
| Financial Health | |
| Debt Ratio | 21.18% |
| Total Debt | $0.00 |
| FCF | $-340M |
| Cash | $118M |
| Current Ratio | 5.72x |
| Performance | |
| 1Y Return | 15.60% |
| 1M Return | 6.97% |
| From 52W High | -29.59% |
| 1Y MDD | -45.14% |
| Trading | |
| Volume | 2,631,177 shares |
| Trading Value | $81M |
| Per Share | |
| EPS | $-3.15 |
| BPS | $5.61 |